Therapeutic Development: Building on early successes, we anticipate second-generation therapies
Udomkun P, Wiredu AN, Nagle M et al (2017) Innovative technologies to manage aflatoxins in foods and feeds and the profitability of application a review
Kinetics and persistence research enabled by long acting analogue design Long acting analogues are frequently used in research settings because they can support extended exposure paradigms and persistence studies without requiring constant preparation changes
Additionally, exposure to toxins, heavy metals, and oxidative stress can disrupt enzymatic activity within the cycle, affecting its overall function and metabolic stability
After treatment, the cells were washed three times with PBS and incubated with 5 M CMFDA at 37 C for 30 min
It is not a licensed medicine and cannot be sold for human or veterinary consumption, and every vial ships labelled for in-vitro research use only